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Promoting biological therapy  
in orthopaedic research
As the population ages the demand for musculoskeletal replacement 
parts increases. Traditional surgery is often based on pure metallic  
and/or ceramics solutions. However, in many cases the biology of the 
human body is not respected. Tissue engineering could be in the lead 
for new solutions with better host integration, better range of motion, 
less inflammation, and lower reoperation rates.
The unmet clinical needs to 
reduce low back pain
The intervertebral disc (IVD) has a very 
limited regenerative potential and disc de­
generation is a major cause of chronic low 
back pain (LBP). This represents a leading 
cause of disability with significant economic 
and social burdens.1 The total economic 
burden of low back pain (LBP) for the Swiss 
society was estimated between 1,6 % and 
2,3 % of the gross domestic product (GDP).2 
The IVD consists of an inner nucleus pulpo­
sus tissue (NP) surrounded by the annulus 
fibrosus (AF) tissue, and hyaline articular 
cartilage located at the endplates between 
the IVD and the vertebral bodies. The gelat­
inous NP is an avascular tissue containing 
a highly organized extracellular matrix rich 
in proteoglycans and collagens with few 
dispersed cells. IVD degeneration implies a 
degradation of the extracellular matrix in 
the NP and the AF resulting in a reduced 
disc height. The exact mechanisms by which 
IVD degeneration is induced are still un­
known. Some risk factors have been identi­
fied, they include ageing, genetic predispo­
sition and stress factors. The degenerative 
changes of the IVD take place early in life 
and the rate of cellular turnover is much 
slower compared to other tissues. 
Current treatments aim to repair the de­
generated disc by replacement of the injured 
tissue with a functional biological substitute 
or prosthesis. Conventional  treatments of IVD 
degeneration are limited since conservative 
or surgical therapies do not restore the IVD 
tissue properties. Since the IVD possesses a 
very limited self­healing capacity, regenera­
tive medicine by injection of cells may repre­
sent a promising therapy for treatment of 
disc degeneration. As such, IVD repair strate­
gies re quire an appropriate cell source that is 
able to regenerate the damaged NP tissue, 
such as progenitor cells. Cell­based therapies 
by injection of IVD cells, chondrocytes, or 
progenitor cells have gained significant atten­
tion and progressed to clinical trials for treat­
ment of spinal disorders.
The knee is a very complex joint 
and prone to problems 
Rupture of the anterior cruciate ligament 
(ACL) is a widespread knee injury. The an­
nual incidence in the US is estimated to lie 
between 100 000 to 200 000 cases.3 ACL 
tears mostly occur as a result of  rotational 
forces alongside varus/valgus stresses act ing 
on the knee. Furthermore, about 80 % of all 
ACL incidences are so called «non­con tact» 
injuries that happen due to unfortu nate 
knee positioning and a strong unopposed 
quadriceps contraction. It is generally well 
accepted that ACL ruptures  have a very poor 
self­healing capacity. Here, further research 
is required for a better understanding why 
ACL have such a poor wound­ healing capa­
city. Non­successful  healing of the ACL has 
the consequence of arthritis and non­physio­
logical mechanical loading in the knee joint. 
Here, novel solutions are re quired that 
would accelerate the wound healing of the 
ACL and would prevent scar formation. Col­
lagen patches wrapped around the ACL in 
combination with a dyn amic fixation system 
could be in the lead for better wound 
 healing. Here, investigations were done how 
these concepts may be applied in a clinically 
relevant ex-vivo set­up, where tendons or li­
gaments can be kept  alive under physiologi­
cal mechanical loading. 
The current focus of the 
TOM research group
The Tissue Engineering for Orthopae­
dics and Mechanobiology group (short 
TOM group) of the Department for Or­
thopedics & Traumatology, Insel Universi­
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 $ Due to an increasing elderly 
population the demand to 
understand the biology of 
musculoskeletal tissues has 
been increased.
 $ Hip implants represent the most 
successful story for orthopaedics 
with very low complication rates 
(around 2 %).
 $ No good solution does yet exist 
for many joints affected by 
degenerative processes, such 
as artificial intervertebral disc 
implants, knee implants, liga­
ment replacements.
 $ The current problems to be 
focused on in orthopaedic re ­
search: inflammation after sur­
gery (complications), metabolic 
diseases affecting bone and 
joints (i. e. osteoporosis, ectopic 
ossification), long lasting pain 
that is often associated with a 
destabilizing spinal column.
 $ Progenitor cells isolated from 
adipose tissue or bone marrow 
might be a cell source for a bio­
logical cell therapy.
 $ Biomaterials are warranted that 
are instructive for specific cell 
phenotypes or may be com­
bined with growth factors that 
maybe slowly released.
 $ The best cell source, however, 
may be the tissue­specific pro­
genitor cells that reside in low 
numbers in all joint tissues.
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Medical Research (DBMR), both Universi-
ty of Bern, conducts translational research 
in the intersection of tissue engineering, 
biology, and applied clinical research. 
The group’s primary aim is to under-
stand the cellular response to biomechani-
cal stimuli and how cellular communities 
are affected in situ using 3D tissue and 
organ culture models (Fig. 1). Our research 
can be divided into two main foci: On the 
one hand the group investigates causes of 
low back pain due to intervertebral disc 
degeneration and on the other hand the 
group focuses on the human knee and the 
shoulder with the aim to identify cell- 
based solutions for the non-healing or de-
layed rupture of the ACL and the rotator 
cuff of the shoulder. The common focus of 
the TOM group is to advance in-vitro organ 
culture models, which match closely the 
human situation and where regenerative 
therapy strategies, such as novel biomate-
rials and cells, can be tested in a most au-
thentic in-vitro set-up (Fig. 1).
Currently, the group investigates a par-
ticular progenitor-cell population that has 
been identified only very recently.  These 
progenitors are positive for Tie2 marker 
(angiopoietin receptor-1). Our team 
 showed that these cells are able to form 
colony-forming units (CFUs) and also can 
be differentiated into different lineages of 
the musculoskeletal apparatus, i. e., adipo-, 
osteo-, and chondrogenic lineages. This 
H2020-funded project called «iPSpine» 
aims to develop further the technology 
around induced progenitor cells (iPS cells) 
and to generate intervertebral disc cells de 
novo from various cell sources (see below).
Novel smart biomimetic materials 
are warranted – silk and hydrogels
In the past, the research team has been 
investigating actively smart biomaterials, 
which are biomimetic and should lead the 
way with new therapies. One of the oldest 
biomaterials with a very low inflammation 
response of the host is silk. Silk was applied 
in orthopaedics for many different applica-
tions, ranging from bone regeneration to 
tendon repair. Figure 2 visualizes the cy-
to-compatibility growing human primary 
cells isolated from the bone marrow or 
from the IVD tissue and how the cells inter-
act with the silk biomaterial. Previous re-
search in the TOM group investigated into 
new growth-factor enriched silk, which has 
been produced from genetically transduced 
silk worms (Bombyx mori), which embed 
the growth factor of interest (in this case 
growth and differentiation factor 6 = GDF6) 
directly into the silk. The new «advanced» 
biomaterial has then been tested in-vitro
with disc cells and mesenchymal stem cells 
but also in an established 3D bovine organ 
culture model and the complex loading bio-
reactor together with a FDA-approved fi-
brin hydrogel. Therefore, a healthy control, 
an injured IVD (2 mm biopsy punch) and 
the repaired IVD were tested and histology 
was performed to visualize the injury and 
integration of the novel silk and fibrin hy-
drogel. These results were recently report-
ed in the Journal of Orthopaedic Research 
and in the Journal of Functionalized Bio-
materials.4, 5 In a collaborative research 
project funded by the Swiss National Sci-
ence Foundation (SNSF) and the German 
Research Funds (Deutsche Forschungsge-
meinschaft = DFG) with Dr. Michael Wöltje, 
Technische Universität Dresden, Germany, 
it is planned to adapt the silk material to-
wards the repair of the outer structure, i. e., 
the annulus fibrosus. Here, silk as a very 
traditional biomaterial will be used again 
but revamped with novel textile and fi-
ber-reinforcement technologies for the ap-
plication of annulus fibrosus repair.
iPSpine project
The consortium leading the iPSpine 
project was formed to initiate a Europe-
an-led research effort to identify a future 
advanced therapeutic strategy that re-
sults in a radical new treatment of LBP 
induced by IVD degeneration. With their 
multidisciplinary expertise in the de-
velopment of advanced therapies and 
their translation from bench to bedside, 
the aim of the iPSpine team is to investi-
gate and develop a new advanced therapy 
medicinal product (ATMP) for the future, 
based on a novel developmental biolo-
gy-based therapeutic strategy employing 
induced pluripotent stem cells (iPSC) and 
smart biomaterials. The iPSpine consor-
tium will develop and demonstrate proof 
of concept with the aid of novel and ex-
tended knowledge, tools and technology 
platforms.
The iPSpine impact: iPSpine seeks to 
offer novel technologies and ATMPs for 
the advanced therapy research and de-
velopment community. IVD degeneration 
will be the showcase, offering improved 
quality of life for millions of patients with 
IVD degeneration-induced LBP, through 
long-lasting reduction of LBP, reduced 
LBP-related premature retirement, and 
improved socio-economic contribution.
Fig. 1:  Bioreactors for the culture of tissues from joints that require mechanical loading. A) Schematic 
drawing (CAD) image of one unit of a 2-degree-of-freedom bioreactor to apply compression and tor-
sion under loading. B) Picture of 4 units inside a standard CO2-bioreactor. C) Way-controlled device 
to apply uni-axial stretching for anterior cruciate ligaments (ACLs). Inlet: CAD image of culture 
chamber for human ACL or tendon (based on Gantenbein et al. 2019)6
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A niche project
As degeneration of the NP is a major 
cause of IVD degeneration, research to-
wards NP cells and NP progenitor cells is 
draw ing increased attention. However, 
caused by difficulties associated with 
their harvest and culture, there are few 
reports investigating the culture methods 
of NP cells (NPCs) and the effects on the 
stemness of these cells.
In this context, the ability to culture 
cells and to investigate the behaviour of 
NPCs in their microenvironment while 
maintaining their gene expression profile 
is essential in experiments using these 
cells. Therefore, understanding the cell 
morphology and gene expression profile 
of NPCs is critical for the development of 
new therapeutic strategies regarding IVD 
degeneration.
It is well documented in the literature 
that the gene expression profile of human 
NPCs is easily lost with conventional two-di-
mensional (2D) monolayer culture, which 
does not replicate the three-dimensional 
(3D) natural environment. It is described as 
hydrophilic aggrecan-rich / glycosaminogly-
can-rich gelatinous extracellular matrix 
(ECM) with unique avascular, hypoxic, nu-
trient-deficient, high osmotic pressure char-
acteristics in which NPCs are naturally sup-
ported. For this reason, to study them in a 
proper way, a novel culture method is requi-
red which allows for the number of NPCs to 
be expanded while maintaining their ex-
pression profile. In our project, we aimed to 
establish and to study novel, efficient pri-
mary culture and subsequent expansion 
culture methods for human NPCs.
Tie2 cells
The IVD has limited regenerative poten-
tial and disc degenera tion is a major cause 
of chronic low back pain. This represents a 
leading cause of dis ability with significant 
economic and social burdens. The IVD con-
sists of an inner nucleus pulposus (NP) sur-
rounded by the annulus fibrosus (AF) tissue. 
The third structure that characterizes the 
IVD is the hyaline articular cartilage, locat-
ed at the endplates between the IVD and the 
vertebral bodies.
The gelatinous NP is an avascular tissue 
containing a highly organized extracellular 
matrix rich in proteoglycans and collagens 
with few dispersed cells. In this respect, the 
NP cells reside within hypoxic conditions, 
since no vasculature enters the NP. Further-
more, disc cells actively regulate the 
homeostasis of the extracellular matrix by 
several cytokines and growth factors acting 
in an autocrine and paracrine fashion.
Conventional treatments for IVD degen-
eration are limited, since conservative or 
surgical therapies do not restore IVD tissue 
properties. Since the IVD has very limited 
healing capacity, regenerative medicine 
(e. g. by injection of cells) may represent a 
promising therapy for treatment of disc 
degeneration. As such, IVD repair strate-
gies require an appropriate cell source that 
is able to regenerate the damaged NP tis-
sue such as progenitor and stem cells.
Progenitor cells do have the advantage 
over terminally differentiated cells that 
they maintain their multipotent differen-
tiation and self-renewal potential in-vivo
and in-vitro under appropriate conditions. 
Furthermore, these cells play an impor-
tant role in the development and homeo-
stasis of the IVD tissue. Recently, proge-
nitor cells that are positive for the angio-
poietin-1 receptor (Tie2) were identified 
in a variety of mammalian’s NP including 
humans. These cells, which express ag-
grecan and collagen type II, were shown 
to have progenitor-like multipotency. 
Tie2 is also known as CD202b, a cellu-
lar membrane receptor tyrosine kinase of 
the Tie family. This receptor contains im-
munoglobulin-like loops and an epider-
mal growth factor (EGF) similar domain 
2. Expressed mainly in endothelial cells, 
the angiopoietin groups of ligands, upon 
binding to their receptor Tie2, are known 
to regulate angiogenesis. Tie2 signaling 
appears to be critical for endothelial 
smooth muscle communication and vas-
cular maturation.
The contribution of Tie2 to IVD 
homeostasis, however, is still poorly under-
stood. Here, we isolated primary nucleus 
pulposus cells (NPC) from human discs 
after trauma and sorted these for the Tie2 
marker. Here the Tie2+ fraction of cells is 
suggested to represent the nucleus pulpo-
sus progenitor cells (NPPC) population. To 
demonstrate the stemness of the Tie2+ 
cells, trilineage (adipogenic, chondrogenic 
and osteogenic) differentiation assays are 
Fig. 2: Scanning Electron Microscope (SEM) images of silk scaffolds produced with electro-spinning. 
A) Human intervertebral disc cells after 1 day of culture seeded on electro-spun silk fibers that are 
randomly aligned. B) Mesenchymal stromal cells (MSCs) seeded on silk produced from electro-spin-
ning collected on a rotating mandrel at 10 Hz. Note the parallel shaped fibers that mimic the outer 
part of an intervertebral disc. C) Human intervertebral disc cells after 1 day of culture seeded onto 
electro-spun silk fibers that were randomly aligned. D) Human MSCs after 7 days of culture on 
salt-leached silk scaffolds, which show the typical porous structure (collaboration with René Rossi 
and Giuseppino Fortunato, Empa, Switzerland)
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performed for the Tie2- and Tie2+ cell pop-
ulations and then their ability to form co-
lonies in methylcellulose-based medium is 
monitored. A second aim will be to address 
the reported difficulties to maintain the 
phenotype of NPPC in culture and to test 
different cell culture conditions to main-
tain and eventually expand these cells 
in-vitro in culture.
Technological progress in the 
advanced therapy field 
The iPSpine consortium will make fun-
damental progress in testing induced plu-
ripotent stem cells (iPSCs) as an alterna tive 
in IVD degeneration treatment strategy, 
studying them and gathering evi dence that 
they are more appropriate in the hos tile 
environment of the degenerative IVD than 
currently employed mesenchymal stem 
cells (MSCs). Smart instructive biomateri-
als will be developed that can be employed 
during manufacturing of the iPSC-based 
therapeutic product. They also serve as the 
ideal carrier to deliver the iPSC-based ther-
apy to the patient and provide mechanical 
support during the regenerative process. 
iPSpine aims to fill several gaps in the de-
velopment of a cell-based therapy for LBP 
identified by the World Health Organiza-
tion. More in details: which type of cells is 
to be used, the mechanisms of action, 
which patients will benefit most (persona-
lized medicine approach), what is the opti-
mal timing to apply the stem cells and what 
is the best way to deliver and track the 
cells. The consortium will have access to 
advanced bioreactor technology, which will 
better mimic the diseased environment of 
the tissue of interest. As such, an improved 
and more thorough screening of possible 
strategies will be possible, whereby the 
consortium can improve the strategy to 
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